tirzepatide vs semaglutide weight loss study semaglutide: A new battle in obesity treatment Tirzepatide vs. Semaglutide: Which GLP-1

And the medication could be mixed with other substances that could cause additional side effects. Having a conversation with a doctor can also help you learn more about the benefits and risks of taking a GLP-1 like semaglutide

Ethics declarations Ethical approval and consent to participate The study was performed according to the tenets of the Helsinki Declaration, and permissions were obtained from the Danish Data Protective Agency (18/16231), the Danish Health Authorities (FSEID-00005826) and the Danish Clinical Registries (DIABASE-2018-12-11)

Foundayo (Orforglipron) Approved in April 2026, Foundayo is the latest in GLP-1 weight loss medications

While this may be helpful for some people, it can become a problem if it leads to poor nutrition or significant weight loss